Latest Updates
-
‘Simple Changes Can Make A Space Feel Lighter And Calmer’: Vastu Expert Gauri Jain On Creating A Positive Home -
‘The Mask’ Star Jim Carrey Marries Longtime Girlfriend Min Ah In Private LA Ceremony -
Salman Khan Flaunts ₹41 Lakh Jacob & Co. Watch With India-Inspired Design, World Map And Dual-Time-Zone -
Nushrratt Bharuccha’s Bali Trip Takes A Serious Turn After Accident, ‘Chhorii’ Actor Airlifted To Mumbai -
Mahalakshmi Vrat 2026: What To Know About Today’s Udyapan, Rituals And Significance -
Jitiya Vrat 2026: Why Mothers Observe The Nirjala Fast, Paran Timings And Rituals Explained -
Drishyam: The Conclusion — Everything You Need To Remember Before Watching The New Film -
Jantar Mantar Protest On Gandhi Jayanti 2026: Why This Delhi Landmark Is A Hub For Public Demonstrations -
World Smile Day 2026: 5 Ways Smiling May Benefit Your Health And Support Everyday Wellbeing -
Lal Bahadur Shastri Jayanti 2026: 10 Quotes That Reflect His Ideas On Leadership, Peace And Nation-Building
Serum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
Serum Institute of India has urged the Union government to include Covovax in the National COVID-19 Vaccination programme for inoculating those aged 12 years and above, official sources said on Tuesday, March 15. The Pune-based SII said it wants to provide Covovax to private hospitals at Rs 900 per dose plus GST and is also waiting for directions to supply the vaccine to the Centre but has not mentioned the price.

India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain conditions on March 9 and for 18 years and above on December 28.
In a letter to Health Secretary Rajesh Bhushan, Director, Government and Regulatory Affairs at SII Prakash Kumar Singh said private companies, educational institutes, social organizations, Central government organizations and Public sector undertakings are making requests for Covovax to inoculate their staffers, families and children, an official source said.
Singh is also learnt to have stated that the Pune-based firm has decided the price of Covovax for supply to private hospitals at the rate of Rs 900 plus GST per dose.
"Also, we are waiting for your kind direction for supplies of our Covovax vaccine to the Government of India," Singh mentioned in his letter.
"Under the visionary leadership of our CEO Adar C Poonawalla, we have developed, manufactured and obtained emergency use authorization from our national regulatory authority for one more world-class COVID-19 vaccine Covovax for 18 years and above on December 28, and for children in the age group of 12 to 17 years on March 9, 2022," an official source quoted Singh as having said in the letter.
He has also requested necessary changes on the CoWin portal for the addition of the Covovax vaccine to inoculate people.
The COVID vaccination for children in the age group of 12 to 14 years will begin from Wednesday. The vaccine to be given to this age group would be Corbevax manufactured by Hyderabad-based Biological E. Limited.



Click it and Unblock the Notifications
